{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:37:22Z","timestamp":1793111842082,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007195","name":"Universit\u00e0 degli Studi di Napoli Federico II","doi-asserted-by":"publisher","award":["Project EGFRIFOSCC-E65F22000050001"],"award-info":[{"award-number":["Project EGFRIFOSCC-E65F22000050001"]}],"id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tvjl.2026.106918","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:12:05Z","timestamp":1791558725000},"page":"106918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a feline Cetuximab with therapeutic potential against feline oral squamous cell carcinoma"],"prefix":"10.1016","volume":"320","author":[{"given":"Gennaro","family":"Altamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7080-0846","authenticated-orcid":false,"given":"Arianna","family":"Finizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Napolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Raia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6454-2824","authenticated-orcid":false,"given":"Emanuele","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9395-3481","authenticated-orcid":false,"given":"Nicola","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Borzacchiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2026.106918_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41587-019-0036-z","article-title":"SignalP 5.0 improves signal peptide predictions using deep neural networks","volume":"37","author":"Almagro Armenteros","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tvjl.2026.106918_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.1040552","article-title":"Anti-EGFR monoclonal antibody Cetuximab displays potential anti-cancer activities in feline oral squamous cell carcinoma cell lines","volume":"9","author":"Altamura","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.tvjl.2026.106918_bib3","article-title":"The small molecule BIBR1532 exerts potential anti-cancer activities in preclinical models of feline oral squamous cell carcinoma through inhibition of telomerase activity and down-regulation of TERT","volume":"7","author":"Altamura","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.tvjl.2026.106918_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/vco.12943","article-title":"Monoclonal antibody cetuximab impairs matrix metalloproteinases 2 and 9, epithelial-mesenchymal transition and cell migration in feline oral squamous cell carcinoma in vitro","volume":"22","author":"Altamura","year":"2024","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2026.106918_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tvjl.2016.11.005","article-title":"Challenges and opportunities for monoclonal antibody therapy in veterinary oncology","volume":"218","author":"Beirao","year":"2016","journal-title":"Vet. J."},{"key":"10.1016\/j.tvjl.2026.106918_bib6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4161\/cbt.11.11.15525","article-title":"Studies on the inhibition of feline EGFR in squamous cell carcinoma: enhancement of radiosensitivity and rescue of resistance to small molecule inhibitors","volume":"11","author":"Bergkvist","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tvjl.2026.106918_bib7","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1128\/JVI.72.12.9992-10002.1998","article-title":"The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells","volume":"72","author":"Cocchi","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.tvjl.2026.106918_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/1568026618666180112162412","article-title":"Cetuximab and the head and neck squamous cell cancer","volume":"18","author":"Concu","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.tvjl.2026.106918_bib9","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1292\/jvms.16-0020","article-title":"Development of a mouse-feline chimeric antibody against feline tumor necrosis factor-alpha","volume":"78","author":"Doki","year":"2016","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.tvjl.2026.106918_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ctrv.2017.11.008","article-title":"Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation","volume":"63","author":"Ferris","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.tvjl.2026.106918_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41568-023-00637-8","article-title":"Fcgamma receptors and immunomodulatory antibodies in cancer","volume":"24","author":"Galvez-Cancino","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tvjl.2026.106918_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123599","article-title":"Defucosylated mouse-dog chimeric Anti-EGFR antibody exerts antitumor activities in mouse xenograft models of canine tumors","volume":"10","author":"Li","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.tvjl.2026.106918_bib13","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1158\/0008-5472.CAN-09-0049","article-title":"Cetuximab\/C225-induced intracellular trafficking of epidermal growth factor receptor","volume":"69","author":"Liao","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.tvjl.2026.106918_bib14","article-title":"Sequence analysis of feline immunoglobulin mRNAs and the development of a felinized monoclonal antibody specific to feline panleukopenia virus","volume":"7","author":"Lu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tvjl.2026.106918_bib15","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.18632\/oncotarget.23766","article-title":"Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration","volume":"9","author":"Maisel","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.tvjl.2026.106918_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.oraloncology.2011.12.012","article-title":"Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma","volume":"48","author":"Martin","year":"2012","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.tvjl.2026.106918_bib17","doi-asserted-by":"crossref","first-page":"8607","DOI":"10.1158\/0008-5472.CAN-10-0850","article-title":"Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma","volume":"70","author":"Martin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.tvjl.2026.106918_bib18","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1038\/s41598-023-31543-6","article-title":"Development of anti-feline PD-1 antibody and its functional analysis","volume":"13","author":"Nishibori","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tvjl.2026.106918_bib19","article-title":"Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies","author":"Sasso","year":"2018","journal-title":"mAbs 10 1060-1072"},{"key":"10.1016\/j.tvjl.2026.106918_bib20","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/1535-7163.MCT-13-0288","article-title":"Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients","volume":"13","author":"Singer","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tvjl.2026.106918_bib21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vetimm.2014.01.012","article-title":"vitro functional characterization of feline IgGs","volume":"158","author":"Strietzel","year":"2014","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.tvjl.2026.106918_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1089\/mab.2022.0009","article-title":"Defucosylated anti-epidermal growth factor receptor monoclonal antibody exerted antitumor activities in mouse xenograft models of canine mammary gland tumor","volume":"41","author":"Tanaka","year":"2022","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.tvjl.2026.106918_bib23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1290\/1071-2690(2001)037<0676:FHANSC>2.0.CO;2","article-title":"Feline head and neck squamous cell carcinoma cell line: characterization, production of parathyroid hormone-related protein, and regulation by transforming growth factor-beta","volume":"37","author":"Tannehill-Gregg","year":"2001","journal-title":"Vitr. Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.tvjl.2026.106918_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tcb.2013.11.002","article-title":"EGF receptor trafficking: consequences for signaling and cancer","volume":"24","author":"Tomas","year":"2014","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.tvjl.2026.106918_bib25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1158\/2326-6066.CIR-15-0184","article-title":"Prospective evaluation of cetuximab-mediated antibody-dependent cell cytotoxicity in metastatic colorectal cancer patients predicts treatment efficacy","volume":"4","author":"Trotta","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.tvjl.2026.106918_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1663990","article-title":"Feline oral squamous cell carcinoma: recent advances and future perspectives","volume":"12","author":"Tutu","year":"2025","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.tvjl.2026.106918_bib27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41568-025-00841-8","article-title":"Advancing cancer research via comparative oncology","volume":"25","author":"Vincze","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tvjl.2026.106918_bib28","article-title":"Current review of monoclonal antibody therapeutics in small animal medicine","volume":"15","author":"Wang","year":"2025","journal-title":"Anim. Open. Access. J. MDPI"},{"key":"10.1016\/j.tvjl.2026.106918_bib29","first-page":"789","article-title":"Progress in palliation: managing pain caused by cancer in veterinary medicine","volume":"64","author":"Williams","year":"2023","journal-title":"Can. Vet. J."},{"key":"10.1016\/j.tvjl.2026.106918_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051325","article-title":"High-throughput monoclonal antibody discovery from phage libraries: challenging the current preclinical pipeline to keep the pace with the increasing mAb demand","volume":"14","author":"Zambrano","year":"2022","journal-title":"Cancers"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326003758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326003758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:07:37Z","timestamp":1793110057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023326003758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":30,"alternative-id":["S1090023326003758"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106918","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a feline Cetuximab with therapeutic potential against feline oral squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106918"}}